Showing results (21-30 of 606) with videos related to
Sort By:
Pageof 61
Current Atherosclerosis Reports|June 9, 2009
Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery diseaseCatherine Fiévet, Bart StaelsCurrent Protocols in Mouse Biology|June 13, 2015
Overview of the Measurement of Lipids and Lipoproteins in MiceAnne Tailleux, Bart StaelsArteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2010
Fibrates, glitazones, and peroxisome proliferator-activated receptorsFanny Lalloyer, Bart StaelsBest Practice & Research. Clinical Endocrinology & Metabolism|December 7, 2007
PPAR agonists: multimodal drugs for the treatment of type-2 diabetesBarbara Gross, Bart StaelsMethods in Molecular Biology (Clifton, N.J.)|November 11, 2015
Luciferase Reporter Assays to Assess Liver X Receptor Transcriptional ActivityMatthew C Gage, Benoit Pourcet, Inés Pineda-TorraNature Reviews. Endocrinology|August 21, 2021
Hepatic sexual dimorphism - implications for non-alcoholic fatty liver diseasePhilippe Lefebvre, Bart StaelsDiabetes & Vascular Disease Research|June 10, 2008
The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolismHélène Duez, Bart StaelsCurrent Obesity Reports|February 12, 2025
Circadian Disruption and the Risk of Developing ObesityHélène Duez, Bart StaelsDrugs|June 30, 2007
Bile acid sequestrants and the treatment of type 2 diabetes mellitusBart Staels, Folkert KuipersPageof 61